Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-06 5:57 pm Purchase |
2020-06-30 | 13D | Fusion Pharmaceuticals Inc. FUSN |
ORBIMED ADVISORS LLC | 2,997,981 7.200% |
2,997,981 (New Position) |
Filing History |
| 2020-07-01 5:31 pm Unchanged |
2020-06-30 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 3,058,267 21.200% |
0 (Unchanged) |
Filing History |
| 2020-06-29 6:27 pm Purchase |
2020-06-17 | 13D | Compass Therapeutics, Inc. CMPX |
ORBIMED ADVISORS LLC | 12,714,404 24.400% |
12,714,404 (New Position) |
Filing |
| 2020-06-25 8:19 pm Purchase |
2020-06-19 | 13D | Repare Therapeutics Inc. RPTX |
ORBIMED ADVISORS LLC | 3,276,325 8.900% |
3,276,325 (New Position) |
Filing History |
| 2020-06-11 4:25 pm Sale |
2020-06-09 | 13D | BELLUS Health Inc. BLU |
ORBIMED ADVISORS LLC | 3,954,800 6.600% |
-988,616 (-20.00%) |
Filing History |
| 2020-06-04 4:58 pm Sale |
2020-06-02 | 13D | Alector, Inc. ALEC |
ORBIMED ADVISORS LLC | 6,466,992 8.200% |
-1,395,400 (-17.75%) |
Filing History |
| 2020-05-26 4:40 pm Purchase |
2020-05-21 | 13D | scPharmaceuticals Inc. SCPH |
ORBIMED ADVISORS LLC | 4,797,148 17.900% |
1,387,283 (+40.68%) |
Filing History |
| 2020-05-22 4:54 pm Sale |
2020-05-20 | 13D | Ascendis Pharma A/S ASND |
ORBIMED ADVISORS LLC | 2,083,713 4.300% |
-435,069 (-17.27%) |
Filing History |
| 2020-05-22 4:54 pm Unchanged |
2020-05-21 | 13D | Turning Point Therapeutics, Inc. TPTX |
ORBIMED ADVISORS LLC | 2,027,550 4.900% |
0 (Unchanged) |
Filing History |
| 2020-05-20 4:54 pm Purchase |
2020-05-06 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 14,014,321 77.700% |
2,400,000 (+20.66%) |
Filing History |
| 2020-05-07 9:48 pm Sale |
2020-05-05 | 13D | Ascendis Pharma A/S ASND |
ORBIMED ADVISORS LLC | 2,518,782 5.200% |
-493,118 (-16.37%) |
Filing History |
| 2020-05-01 4:15 pm Purchase |
2020-04-28 | 13D | ORIC Pharmaceuticals, Inc. ORIC |
ORBIMED ADVISORS LLC | 2,765,717 9.200% |
2,765,717 (New Position) |
Filing History |